Mölnlycke Health Care acquires Sundance Solutions

Mölnlycke Health Care acquires Sundance Solutions, establishing a leadership position in pressure ulcer prevention

February 15 2016

Gothenburg, Sweden/ White Plains, NY, USA. February 15, 2016

Mölnlycke Health Care, a world-leading provider of high-quality healthcare solutions, announced today the acquisition of Sundance Solutions, a leader in developing innovative solutions for the safe positioning and turning of patients to help prevent pressure ulcers.

Two nurses positioning a patient using the Tortoise turning, positioning and offloading system

Sundance's proprietary solutions include Tortoise™, a unique and simple turning, positioning and offloading system that is easy to use, safe for both patients and caregivers. Together with its fluidized media technology, they complement Mölnlycke's portfolio of advanced dressing solutions – offering clinicians a more complete and unique range of tools to ensure better patient outcomes. Sundance's annual revenues amount to approximately USD 25 million.

The acquisition will combine the distinctive and complementary strengths of two innovators in the field of pressure ulcer prevention – delivering unique value for healthcare professionals and providers.

Richard Twomey, CEO, Mölnlycke Health Care said, "We are very enthusiastic about joining forces with Sundance Solutions, thereby taking a huge step forward to help patients, their families, and caregivers prevent pressure ulcers. Pressure ulcers represent a huge burden of sickness and reduced quality of life for patients, and they are a major challenge for clinicians. At a time when healthcare providers are pressed to both reduce costs and maintain and improve patient care, Mölnlycke is committed to help them achieve both better patient outcomes and financial savings."

William Purdy, CEO of Sundance Solutions commented, "We are delighted to join Mölnlycke Health Care as a recognized global leader in medical devices that shares our company values. We are very happy that our unique line of pressure ulcer prevention products will now be available through a trusted industry pioneer such as Mölnlycke."

Pressure ulcers are a frequently-occurring, costly, avoidable side effect of patient care, affecting 2.5 million patients per year in the USA and costing up to $11.6 billion per year.1 It is estimated that up to 30% of hospital patients, as well as 20% of patients in nursing and residential homes, may suffer from the condition.2 The cost of individual patient care can range from $20,000 to $150,000 per pressure ulcer.1

For several years Mölnlycke Health Care has contributed to the prevention of pressure ulcers through its range of advanced dressing solutions with Safetac®. The results of over 30 clinical and economic studies, including data from randomized controlled trials, demonstrate that the use of multi-layer foam dressings with Safetac – such as Mepilex® Border Sacrum and Mepilex® Border Heel – can reduce the occurrence of pressure ulcers as a component of standard preventive measures3.



  1. Agency for Healthcare Research and Quality. Preventing pressure ulcers in hospitals. www.ahrq.gov/professionals/systems/hospital/pressureulcertoolkit/putool1.html
  2. NHS Institute for Innovation and Improvement. Your skin matters. www.institute.nhs.uk/building_capability/general/your_skin_matters.html
  3. Davies, P. Role of multi-layer foam dressings with Safetac in the prevention of pressure ulcers: a review of the clinical and scientific data. Journal of Wound Care 2016; 25(1): S1-S24.



Notes for editors

About Mölnlycke Health Care

Mölnlycke Health Care is a provider of high-quality healthcare solutions for customers, healthcare professionals and patients worldwide. We develop and bring to market innovative wound care and surgical solutions along the entire continuum of care – from prevention to post-acute settings. Our solutions provide value for money, supported by clinical and health economic evidence.
Our headquarters are located in Gothenburg, Sweden, and we employ 7,500 people with offices and factories worldwide. We are owned by Investor AB.

Our wound care range includes gentle, effective dressings with Safetac, such as Mepitel® and Mepilex®, to prevent, protect and heal a wide range of wounds. We also provide safe, efficient, single-use surgical products, such as Biogel® surgical gloves and ProcedurePak® trays – to minimize infections and increase efficiency in the operating room and beyond. We also provide solutions for negative pressure wound therapy.

About Sundance Solutions

Based in White Plains, New York, Sundance Enterprises, Inc. is a leader in the development, manufacture, and marketing of unique patient therapeutic positioning products, heel protection, patient turning, and pressure reduction products.

Since our inception Sundance has followed the maxim that research, development and clinical collaboration is the foundation for improved patient care. From our original static air immersion pressure reduction systems, to the highest level of pressure relief and positioning systems, Sundance products continue to make a significant impact on the lives of patients and the ability of caregivers to more effectively and safely do their jobs. Our research continues with a focus on innovative technology to develop products and process for better patient outcomes.

Press contact

Bodil Czarnecki
Corporate Communications

Direct: +46 31 722 30 37
Mobile: +46 739 41 25 37

Contact form